Pentax Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.18 M
as on 04-12-2024
- Company Age 32 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.48 Cr
as on 04-12-2024
- Satisfied Charges ₹ 27.04 Cr
as on 04-12-2024
- Revenue -5.07%
(FY 2019)
- Profit 24.64%
(FY 2019)
- Ebitda -0.84%
(FY 2019)
- Net Worth 17.69%
(FY 2019)
- Total Assets 16.82%
(FY 2019)
About Pentax Pharma
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹8.48 Cr. The company has closed loans amounting to ₹27.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pragnyat Lalwani and Gautam Jain serve as directors at the Company.
- CIN/LLPIN
U24139MH1992PTC068429
- Company No.
068429
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pentax Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pragnyat Lalwani  | Director | 07-Sep-1993 | Current |
| Gautam Jain | Director | 17-Jan-1994 | Current |
Financial Performance and Corporate Structure Insights of Pentax Pharma.
Pentax Pharma Pvt Ltd, for the financial year ended 2019, experienced Minor drop in revenue, with a 5.07% decrease. The company also saw a substantial improvement in profitability, with a 24.64% increase in profit. The company's net worth Soared by an impressive increase of 17.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pentax Pharma?
In 2019, Pentax Pharma had a promoter holding of 76.92% and a public holding of 23.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prayaas Automation Private LimitedActive 22 years 10 monthsPragnyat Lalwani and Gautam Jain are mutual person
Seshaasai Business Forms Pvt LtdActive 31 years 3 monthsPragnyat Lalwani and Gautam Jain are mutual person
Dandelion Technologies Private LimitedActive 3 years 23 daysPragnyat Lalwani and Gautam Jain are mutual person
Srichakra Infratech Private LimitedActive 20 years 1 dayPragnyat Lalwani and Gautam Jain are mutual person
- Qupod Technovations Private LimitedActive 11 years 4 months
Pragnyat Lalwani and Gautam Jain are mutual person
- Seshaasai Datagenie Private LimitedActive 5 years 6 months
Pragnyat Lalwani and Gautam Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 May 2019 | ₹8.48 Cr | Open |
Axis Bank Limited Creation Date: 08 Dec 2016 | ₹7.00 Cr | Satisfied |
The Greater Bombay Co-Op Bank Ltd Creation Date: 11 Dec 2013 | ₹1.58 Cr | Satisfied |
How Many Employees Work at Pentax Pharma?
Unlock and access historical data on people associated with Pentax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pentax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pentax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
